Skip to main content

Cabaletta Bio, Inc.

CABA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001759138

No open-market purchases or sales by Cabaletta Bio, Inc. insiders were filed in the last 90 days; 139 institutions reported holding it in 13F filings for Q2 2026, worth $490.4M in total; no superinvestor holds it.

Q3 2025 vs. Q2 2025

How the institutions holding Cabaletta Bio, Inc. changed between Q2 2025 and Q3 2025.

All holders in Q3 2025All holders in Q2 2025

13F holders of CABA: Q2 2025 compared with Q3 2025
MeasureQ2 2025Q3 2025Change
Holders8675−11
Shares72.8M69.2M−3.55M (−4.9%)
Value$110.7M$162.0M+$51.3M (+46.3%)

New holders (10)

Institutions that held Cabaletta Bio, Inc. at the end of Q3 2025 but not at the end of Q2 2025.

Institutions new to CABA in Q3 2025
InstitutionSharesValue% of portfolio
Opaleye Management Inc.808,882$1.89M0.27%
Qube Research & Technologies Ltd89,157$208.6K0.00%
Quadrature Capital Ltd42,912$100.4K0.00%
Susquehanna Portfolio Strategies, LLC33,937$79.4K0.00%
Jones Financial Companies LLLP20,007$47.2K0.00%
American Century Companies Inc12,032$28.2K0.00%
Caitong International Asset Management Co., Ltd8,983$21.0K0.01%
Optiver Holding B.V.24$560.00%
SRS Capital Advisors, Inc.10$230.00%
Northwestern Mutual Wealth Management Co2$50.00%

Sold out (21)

Institutions that held Cabaletta Bio, Inc. at the end of Q2 2025 and filed for Q3 2025 without it.